PetVivo Holdings Inc. (PETV) stock went up by a further 12.70% in the aftermarket at $3.55 on December 02. In the previous trading session, the stock had gone up by 3.62% to close at $3.15 with 930K shares exchanging. PETV seems to continue trading in green since the company launched a digital media campaign. On November 29, the company announced the launch of its digital media campaign for developing its image. This announcement has led the stock to gain 8.25% in the previous five days while PETV has actually gone down by 5.41% in the past month.
The veterinary biotech and biomedical PetVivo Holdings Inc. (PETV) has a market capital of $29.58 million. Currently, the company has 9.73 million outstanding shares in the market.
PETV’s Digital Media Campaign
The company’s recently launched digital media campaign is mainly targeted at creating a positive image and message about PETV and its products. The campaign will include various types of broadcasts like technical interviews, commercials, and digital billboard ads. It is produced by FMW Media Corp. Moreover, it will include 40 interviews and almost 600 30-second T.V commercials. At least 50 commercials would be broadcast per month. In addition, the company will also run at least 2400 15-second commercial ads per day on digital billboards.
The campaign will innovatively inform the public about PETV’s Sprying. Sprying is a therapeutic product that assists in overcoming the effects of lameness in pet animals.
Other Recent Developments
More recently, the company announced its exhibition in the Unites States’ largest veterinary equine conference AAEP. PETV will introduce its lead product SpryingTM with OsteoCushionTM at the American Association Equine Practitioners conference on December 08. The C.E.O of PetVivo, John Lai commented that the company is very hopeful about the networking opportunities in the conference with leaders in the industry.
PETV’s Financial Results
On November 15, PetVivo Holdings Inc. (PETV) announced its financial results for the second quarter of fiscal 2022. As per the Q2 fiscal 2022, the company had revenue of $4,977 against $4,790 in the year-ago period.
Moreover, the G&A expenses were $756,186 for the second quarter of fiscal 2022. Further, the S&M expenses were $235,767 and R&D expenses were $116,380 in the second quarter of fiscal 2022. In addition, other expenses for the quarter were $2,118.
The second quarter of fiscal 2022, incurred a net loss of $1,105,474 or $0.13 per share. In comparison, the net loss in the year-ago period was $1,348,002 or $0.23 per share.
